Cheryl Gould, NP
Psychiatric/Mental Health · Orlando, FLNPI 1942322110
Payments from drug & device makers
Across 41 payments — averaging $192.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Alkermes, Inc.$3K
- Teva Pharmaceuticals USA, Inc.$372
- Johnson & Johnson$353
- Neurocrine Biosciences, Inc.$344
- Otsuka America Pharmaceutical, Inc.$251
- plus $211 from 2 others
What the payments were for
- Speaking & faculty fees$5,97576%
- Food & beverage$1,91724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $3,345 |
| Alkermes, Inc. | 11 | $3,017 |
| Teva Pharmaceuticals USA, Inc. | 3 | $372 |
| Johnson & Johnson | 10 | $353 |
| Neurocrine Biosciences, Inc. | 2 | $344 |
| Otsuka America Pharmaceutical, Inc. | 2 | $251 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $134 |
| Lundbeck LLC | 4 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$11,180
- VRAYLAR$3,300
- ARISTADA INITIO$2,795
- AUSTEDO$372
- INGREZZA$169
- REXULTI$126
- ABILIFY MAINTENA$125
- INVEGA SUSTENNA$121
- SPRAVATO$117
- CAPLYTA$107
- VIVITROL$100
How this compares
$7,892 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 38 | $2,374 |
| Bupropion XlBupropion Hcl | 74 | $2,357 |
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $1,433 |
| Aripiprazole | 18 | $1,113 |
| Fluoxetine Hcl | 53 | $434 |
| Buspirone Hcl | 40 | $419 |
| Bupropion Hcl SrBupropion Hcl | 27 | $375 |
| Atomoxetine Hcl | 16 | $369 |
| Doxepin Hcl | 12 | $321 |
| Sertraline Hcl | 68 | $314 |
| Escitalopram Oxalate | 55 | $246 |
| Alprazolam | 36 | $233 |
| Zolpidem Tartrate | 37 | $205 |
| Hydroxyzine Hcl | 14 | $173 |
| Trazodone Hcl | 31 | $168 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.